ArticleCancer research communications2026

ZSTK3744, a Novel Aryl Hydrocarbon Receptor Agonist, Exhibits Efficacy against Chemotherapy-Resistant Triple-Negative Breast Cancer.

Takahiro Ohashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.